Large-scale separation of silybin diastereoisomers using lipases

Process Biochemistry

Volumn 45, Issue 10, 2010, Pages 1657-1663

  Gažák, Radek ^a   Marhol, Petr ^a   Purchartová, Kateřina ^a   Monti, Daniela ^b   Biedermann, David ^a   Riva, Sergio ^b   Cvak, Ladislav ^c   Křen, Vladimír ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b CNR   (Italy)

^c TEVA PHARMACEUTICALS   (Israel)

Author keywords

Diastereoselectivity; Lipase; Novozym 435; Silibinin; Silybin A; Silymarin

Indexed keywords

DIASTEREO-SELECTIVITY; NOVOZYM435; SILIBININ; SILYBIN; SILYMARIN;

ACETYLATION; PLANTS (BOTANY); STEREOSELECTIVITY;

LIPASES;

CANDIDA ANTARCTICA; SILYBUM MARIANUM;

EID: 77956174741     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2010.06.019     Document Type: Article

References (39)

1. Gažák R., Walterová D., Křen V. Silybin and silymarin-new and emerging applications in medicine. Curr Med Chem 2007, 14:315-338.
2. Morazzoni P., Bombardelli E. Silybum marianum (Carduus marianus). Fitoterapia 1995, 66:3-42.
3. Sobolová L., Škottová N., Večeřa R., Urbánek K. Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats. Pharmacol Res 2006, 53:104-112.
4. Schrall R., Becker H. Callus- und Suspensionskulturen von Silybum marianum. Planta Med 1977, 32:27-32.
5. Lee D.Y.-W., Liu Y. Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, isolated from Silybum marianum (milk thistle). J Nat Prod 2003, 66:1171-1174.
6. Kim N.-C., Graf T.N., Sparacino C.M., Wani M.C., Wall M.E. Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). Org Biomol Chem 2003, 1:1684-1689.
7. Křen V., Sedmera P., Kubisch J., Halada P., Přikrylová V., Jegorov A., et al. Glycosylation of silybin. J Chem Soc, Perkin 1997, 1:2467-2474.
8. Kosina P., Křen V., Gebhardt R., Grambal F., Ulrichová J., Walterová D. Antioxidant properties of silybin glycosides. Phytother Res 2002, 16:S33-S39.
9. Šimánek V., Křen V., Ulrichová J., Vičar J., Cvak L. Silymarin: what is in the name?. Hepatology 2000, 32:442-443.
10. Křen V. Silibinin chirality. J Photochem Photobiol A: Chem 2009, 203:222-223.
11. Flora K., Hahn M., Rosen H., Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998, 93:139-143.
12. Křen V., Walterová D. Silybin and silymarin-new effects and applications. Biomed Pap 2005, 149:29-41.
13. Trouillas P., Marsal P., Svobodová A., Vostálová J., Hrbáč J., Gažák R., et al. Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. J Phys Chem A 2008, 112:1054-1063.
14. Gažák R., Sedmera P., Vrbacký M., Vostálová J., Drahota Z., Marhol P., et al. Molecular mechanisms of silybin and 2,3-dehydrosilybin antiradical activity-role of individual hydroxyl groups. Free Radic Biol Med 2009, 46:745-758.
15. Gažák R., Sedmera P., Marzorati M., Riva S., Křen V. Laccase-mediated dimerization of the flavonolignan silybin. J Mol Catal B: Enzym 2008, 50:87-92.
16. Gažák R., Svobodová A., Psotová J., Sedmera P., Přikrylová V., Walterová D., et al. Oxidised derivatives of silybin and their antiradical and antioxidant activity. Bioorg Med Chem 2004, 12:5677-5687.
17. Agarwal R., Agarwal C., Ichikawa H., Singh R.P., Aggarwal B.B. Anticancer potential of silymarin: from bench to bed side. Anticancer Res 2006, 26:4457-4498.
18. Singh R.P., Agarwal R. Prostate cancer chemoprevention by silibinin: bench to bedside. Mol Carcinog 2006, 45:436-442.
19. Džubák P., Hajdúch M., Gažák R., Svobodová A., Psotová J., Walterová D., et al. New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and P-glycoprotein modulatory activity. Bioorg Med Chem 2006, 14:3793-3810.
20. Davis-Searles P.R., Nakanishi Y., Kim N.-Ch., Graf T.N., Oberlies N.H., Wani M.C., et al. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res 2005, 65:4448-4457.
21. Plíšková M., Vondráček J., Křen V., Gažák R., Sedmera P., Walterová D., et al. Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation. Toxicology 2005, 215:80-89.
22. Křen V., Minghetti A., Sedmera P., Havlíček V., Přikrylová V., Crespi-Perellino N. Glucosylation of silybin by plant cell cultures of Papaver somniferum var. setigerum. Phytochemistry 1998, 47:217-220.
23. Křen V., Ulrichová J., Kosina P., Stevenson D., Sedmera P., Přikrylová V., et al. Chemoenzymatic preparation of silybine β-glucuronide and their biological evaluation. Drug Metab Dispos 2000, 28:1513-1517.
24. Polyak S.J., Morishima C., Lohmann V., Pal S., Lee D.Y.W., Liu Y., et al. Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci USA 2010, 107:5995-5999.
25. Li W., Han J., Li Z.N., Li X., Zhou S., Liu C. Preparative chromatographic purification of diastereomers of silybin and their quantification in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B 2008, 862:51-57.
26. Graf T.N., Wani M.C., Agarwal R., Kroll D.J., Oberlies N.H. Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (milk thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention. Planta Med 2007, 73:1495-1501.
27. Křen V., Gažák R., Purchartová K., Marhol P., Biedermann D., Sedmera P. Chemoenzymatic preparative separation of silybins A and B. J Mol Catal B: Enzym 2009, 61:247-251.
28. Ghanem A. Trends in lipase-catalyzed asymmetric access to enantiomerically pure/enriched compounds. Tetrahedron 2007, 63:1721-1754.
29. Wong C.-H., Whitesides G.M. Enzymes in synthetic organic chemistry 1994, Pergamon Press, Oxford.
30. Muralidhar R.V., Chirumamilla R.R., Marchant R., Ramachandran V.N., Ward O.P., Nigam P. Understanding lipase stereoselectivity. World J Microbiol Biotechnol 2002, 18:81-97.
31. Monti D., Gažák R., Marhol P., Biedermann D., Purchartová K., Fedrigo M., et al. Enzymatic kinetic resolution of silybin diastereoisomers. J Nat Prod 2010, 73:613-619.
32. Gažák R., Purchartová K., Marhol P., Živná L., Sedmera P., Valentová K., et al. Antioxidant and antiviral activities of silybin fatty acid conjugates. Eur J Med Chem 2010, 45:1059-1067.
33. Chen C.S., Fujimoto Y., Girdaukas G., Sih C.J. Quantitative analyses of biochemical kinetic resolutions of enantiomers. J Am Chem Soc 1982, 104:7294-7299.
34. Hanefeld U., Gardossi L., Magner E. Understanding enzyme immobilisation. Chem Soc Rev 2009, 38:453-468.
35. Cabrera Z., Fernandez-Lorente G., Fernandez-Lafuente R., Palomo J.M., Guisan J.M. Novozym 435 displays very different selectivity compared to lipase from Candida antarctica B adsorbed on other hydrophobic supports. J Mol Catal B: Enzym 2009, 57:171-176.
36. Theodosiou E., Katsoura M.H., Loutrari H., Purchartová K., Křen V., Kolisis F.N., et al. Enzymatic preparation of acylated derivatives of silybin in organic and ionic liquid media and evaluation of their antitumor proliferative activity. Biocatal Biotransform 2009, 27:161-169.
37. Carrea G., Ottolina G., Riva S. Role of solvents in the control of enzyme selectivity in organic media. Trends Biotechnol 1995, 13:63-70.
38. 6), the first flavonolignan. Tetrahedron Lett 1968, 25:2911-2916.
39. Bandopadhyay M., Pardeshi N.P., Seshadri T.R. Components of Silybum marianum. Indian J Chem 1972, 10:808-809.